Skip to search formSkip to main contentSkip to account menu

22q13.3 Deletion Syndrome

Known as: PHELAN-MCDERMID SYNDROME, Telomeric 22q13 Monosomy Syndrome, Deletion 22q13 Syndrome 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
SHANK3 (also known as PROSAP2) is a postsynaptic scaffolding protein at excitatory synapses in which mutations and deletions have… 
Review
2015
Review
2015
Several diseases have been successfully modeled since the development of induced pluripotent stem cell (iPSC) technology in 2006… 
Review
2014
Review
2014
Autism spectrum disorder (ASD) and intellectual disability (ID) can be caused by mutations in a large number of genes. One… 
Review
2014
Review
2014
Glutamate is the major excitatory neurotransmitter in the brain and may be a key neurotransmitter involved in autism. Literature… 
Highly Cited
2011
Highly Cited
2011
Background The clinical features of Phelan–McDermid syndrome (also known as 22q13 deletion syndrome) are highly variable and… 
2011
2011
Chromosome 22q13 monosomy has been described as a contiguous gene syndrome. Localized in the critical region, SHANK3 is likely to… 
Highly Cited
2008
Highly Cited
2008
Background: The 22q13 deletion syndrome (Phelan–McDermid syndrome) is characterised by a global developmental delay, absent or… 
Highly Cited
2007
Highly Cited
2007
1. Aquatic insects emerging from streams can provide an important energy subsidy to recipient consumers such as riparian web… 
Review
2004
Review
2004
Recent advances in genetic testing can help to provide a specific diagnosis to children born with syndromes that result in…